Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga; Teresa Freire; Luis Ubillos

doi:10.1002/ijc.30246

Journal Articles International Journal of Cancer Year : 2016

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

(1, 2) , (1, 2) , (2)

1
2

Eduardo Osinaga

Function : Author

Institut Pasteur de Montevideo

Departamento de inmunobiologia

Teresa Freire

Function : Author

Institut Pasteur de Montevideo

Departamento de inmunobiologia

Luis Ubillos

Function : Author

Departamento de inmunobiologia

Domains

Life Sciences [q-bio]

Mariella Botta : Connect in order to contact the contributor

https://hal-riip.archives-ouvertes.fr/pasteur-01499032

Submitted on : Thursday, March 30, 2017-8:20:24 PM

Last modification on : Tuesday, January 18, 2022-2:50:08 PM

Dates and versions

pasteur-01499032 , version 1 (30-03-2017)

Identifiers

HAL Id : pasteur-01499032 , version 1
DOI : 10.1002/ijc.30246
PUBMED : 27352000

Cite

Eduardo Osinaga, Teresa Freire, Luis Ubillos. Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?. International Journal of Cancer, 2016, 139 (9), pp.2144. ⟨10.1002/ijc.30246⟩. ⟨pasteur-01499032⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

RIIP RIIP_MONTEVIDEO

16 View

0 Download

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share